Le Lézard
Classified in: Health, Science and technology
Subject: PER

Geneia Names Chief Medical Officer


HARRISBURG, Pa., May 10, 2018 /PRNewswire/ -- Geneia (www.Geneia.com), a healthcare analytic solutions and services company that is simplifying the evolution to value-based care, appointed Aurel O. Iuga, MD, MBA, MPH, CMQ as chief medical officer.

 (PRNewsfoto/Geneia)

"Dr. Iuga's extensive experience in data-driven population health and developing clinical algorithms used to stratify populations, anticipate their medical needs and improve outcomes will help Geneia's growing client base succeed in their value-based reimbursement arrangements," said Geneia CEO Mark A. Caron, FACHE, CHCIO.

Board-certified in clinical informatics, preventive medicine and public health, Iuga brings an expertise in population health, clinical strategy and clinical algorithm development. Most recently, he served as medical director and clinical solutions manager for Anthem's clinical modeling group. Iuga's experience also includes tenure as a healthcare strategy consultant and as a research fellow at Massachusetts General Hospital and Harvard Medical School.

"It's an exciting time to join Geneia," said Iuga. "As we move from predictive to prescriptive analytics, our health plan, provider and employer clients are increasingly able to do true population and personalized health."

To learn more about Dr. Iuga, visit: https://www.geneia.com/about-us/our-team/aurel-iuga.

ABOUT GENEIA
Geneia LLC is a healthcare analytic solutions and services company that focuses on improving systems to support personalized, patient-centered care. We help clients improve outcomes, lower costs and restore the Joy of Medicine to physician practice. Our technology, education and training, insights and clinical services simplify the evolution to value-based care and drive alignment and collaboration among healthcare providers, health plans and employers. The company has offices in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Twitter and LinkedIn.

SOURCE Geneia


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: